The Opal - COVID-19 Study

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
COVID-19
Interventions
OTHER

sociodemographic and health, daily self-assessment, and feasibility of using the Opal app for COVID

The intervention consists of having confirmed COVID-19 infected participants register for the Opal app and complete a daily questionnaire on symptoms related to their physical and mental health as well as on certain key vital signs (e.g., oxygen saturation, heart rate, temperature). A nurse will check the questionnaire results each day and determine the need for a teleconsultation with an infectious disease physician. Participants will be followed up for a minimum of 14 days, depending on their symptoms.

Trial Locations (1)

H4A3T2

Research Institute of the McGill University Health Centre, Montreal

All Listed Sponsors
lead

Dr. Bertrand Lebouche

OTHER

NCT04978233 - The Opal - COVID-19 Study | Biotech Hunter | Biotech Hunter